Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

  • Donate Today

    Donate Today

    Support families, advance research, and give to NTSAD.

  • Newly Diagnosed?

    Newly Diagnosed?

    Support and mentorship is here as you cope with a diagnosis of Canavan, GM1, Sandhoff or Tay-Sachs.

  • Clinical Trials

    Clinical Trials

    Learn more about the clinical trials in development that we hope lead to effective therapies.

  • NTSAD's New Website

    NTSAD's New Website

    Check out a sneak peek into NTSAD's new website.

  • Annual Family Conference 2023

    Annual Family Conference 2023

    Join the NTSAD Community from June 1-4, 2023 in Reston, Virginia.
  • We Care for Rare

    We Care for Rare

    Meet Rare Families. Read More
  • Be an advocate!

    Be an advocate!

    Your voice is important and can have a profound impact on legislation that affects our small but mighty rare disease community.

  • › ‹
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7

Latest News

  • 1
  • 2
  • 3
  • 4
› ‹

Disease Name

Enzyme affected

Gene containing mutation

Substrate that accumulates

Tay Sachs

Beta- hexosaminidase A

HEXA

GM2 Ganglioside

Sandhoff

Beta-Hexosaminidase A & Beta-Hexosaminidase B

HEXB

GM2 Ganglioside

GM-1

Beta-galactosidase

GLB1

GM1 Ganglioside

Fabry

Alpha-galactosidase A

GLA

Globotriaoslyceramide

Gaucher

Beta-glucocerebrosidase

GBA

Glucocerebroside

Niemann-Pick Types A & B

Acid-sphingomyelinase

SMPD1

Spingomyelin

Niemann-Pick Type C*

 

NPC1 or NPC2

 

Pompe**

Acid alpha-glucosidase (acid maltase)

GAA

Glycogen

 

*Mutations in the NPC1 or NPC2 genes cause a problem with the transport of lipids (fatty substances) in the cell. These lipids then build up in the cells, which causes cell dysfunction. There is further cell dysfunction because the lipids are not taken to the location where they are needed in the cell.

**Pompe is also a glycogen storage disorder.

Login